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Abstract 
 The anticholinesterase paraoxon (Pxn) is an organophosphate (OP) and 
the active metabolite of the insecticide parathion. It potently inhibits the 
enzyme acetylcholinesterase and leads to enhanced glutamate release, 
diminished GABA uptake, oxidative damage, and neurodegeneration. The 
resulting increased levels of acetylcholine can trigger seizures and cause 
neuronal and excitotoxic damage in the brain. The brain susceptibility related 
to anticholinesterase toxins extends beyond potential brain damage and death 
from toxic levels of the agent. Asymptomatic low-level exposure to such 
toxins can also leave the brain vulnerable or even cause it to exhibit 
neurological problems later in life. The actions of Pxn and similar neurotoxins 
have been studied in order to examine the events associated with 
anticholinesterase toxicity in the brain. A recent study demonstrated that Pxn 
exposure initiates a pathogenic cascade involving seizure events and 
subsequent signs of damage including unique presynaptic vulnerability and 
associated behavioral deficits. In addition, Pxn-mediated synaptotoxicity is 
also associated with enhanced production of oxidative stress as well as integrin 
adhesion responses. These findings provide a better understanding of the 
molecular events involved in Pxn toxicity. 
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 Paraoxon (Pxn), an anticholinesterase toxin, is in the organophosphate 
(OP) class of compounds that includes insecticides and military nerve agents 
(e.g. soman and sarin). Exposure to OP toxins is one of the most common 
causes of poisoning worldwide, affecting nearly 3 million people each year, 
of which approximately 15% die as a result of the poisoning (Eddleston et al., 
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2008). Exposure can occur through drinking contaminated water, breathing 
vapors of the toxins, or subjecting a person’s skin to contact with the toxin. In 
the central nervous system (CNS), such agents classified as neurotoxins and 
environmental toxins alter cholinergic, glutamatergic, and GABAergic 
pathways and can lead to seizures, brain damage, and different neurological 
syndromes.  
 Understanding the toxic action of anticholinesterase compounds is 
vital in order to identify pathogenic steps involved and which of these steps 
lead to disruptions in synaptic integrity and communication. Pxn, the oxidized 
active metabolite of the insecticide parathion, has become a common research 
target to study anticholinesterases (Krutak-Krol and Domino, 1985; Harrison 
et al., 2004; Todorovic et al., 2012; Deshpande et al., 2014). Pxn causes the 
accumulation of acetylcholine in synapses and results in a cholinergic crisis 
in the brain (Wei et al. 2014). Enhanced levels of acetylcholine can trigger 
seizures, long-term behavioral changes, elongated epileptiform action, and 
reduced cognition (Sánchez-Santed et al., 2004; Millett, 2006; Prager et al., 
2015). In humans, acute OP poisoning also leads to respiratory failure and, 
hence, can cause death (Eddleston et al., 2005).  
 The brain’s susceptibility related to anticholinesterase toxins extends 
beyond brain damage and death from toxic levels of the agent. Asymptomatic 
low-level exposure can also leave the brain vulnerable to subsequent brain 
insults (see Munirathinam and Bahr, 2004). Even neonatal low-doses of 
exposure to toxic substances such as pesticides can potentiate brain 
vulnerability to different types of insults in adulthood (Eriksson and Talts, 
2000). In addition, repeated exposure to related pesticides has been linked to 
an increased risk for Alzheimer's disease later in life (Hayden et al., 2010; 
Sánchez-Santed et al. 2016). Nerve agent exposure is particularly detrimental 
to the neurodevelopmental processes underlying synaptic connectivity and 
cognitive ability (Rotenberg and Newmark, 2003). As a result, children are 
particularly vulnerable to anticholinesterase toxin exposure.   
 Animal models have been used extensively to understand the effects 
of anticholinesterase insults and their relationship to brain damage in humans. 
Harrison and colleagues (2004) found that, in guinea pigs, Pxn caused seizures 
similar to those caused by the nerve gas soman in humans. Likewise, the 
anticholinesterase potency of Pxn was similar in macaques and humans 
(Worek et al., 2011). Furthermore, Rosenberg and colleagues (2017) showed 
that anticholinesterase-exposed macaques presented severe signs of toxicity 
(e.g. fasciculations, miosis, salivation, and convulsions), and many died in less 
than seven hours post-application. This type of research potentially offers an 
approach to evaluate and better understand the underlying mechanisms of 
toxins with actions that trigger brain disturbances.  
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 Certain neurotoxins like Pxn act not only on the cholinergic network, 
but also affect other neurotransmitter systems involved in excitotoxic 
propagation. Pxn enhances glutamatergic transmission on hippocampal 
granule cells. This effect is postulated to occur principally through presynaptic 
mechanisms (Kozhemyakin et al., 2010). It is noteworthy that the stimulation 
of nicotinic receptors by itself leads to an increase in glutamate release and 
thereby increases synaptic transmission in the hippocampus (Sharma and 
Vijayaraghavan 2003; Alkondon and Albuquerque 2004). Similarly, 
anticholinesterase agents such as Pxn lead to an over-stimulation of nicotinic 
and muscarinic receptors through the accumulation of acetylcholine. 
Pavlovsky and colleagues (2003) previously reported the interaction between 
these two systems and showed acetylcholine-dependent enhancement of 
glutamatergic excitatory transmission. Subsequently, Mohammadi and 
colleagues (2008), also found GABA uptake was significantly reduced in both 
the cerebral cortex and hippocampus of Pxn-treated rats. Such evidence 
suggests that acute exposure to anticholinesterase agents not only triggers a 
cholinergic crisis but occurs in correspondence with the release of excitotoxic 
levels of glutamate from excitotoxic-sensitive regions of the brain.  
 Excitotoxic insults are thought to be involved in dendritic and synaptic 
damage, early toxicological signs that lead to neuronal dysfunction and 
memory impairment (Munirathinam and Bahr, 2004; Raveh et al., 2002, 
2003). Functional imaging during an excitotoxicity study suggests that during 
seizures, limbic structures such as the amygdala, piriform cortex, entorhinal 
cortex, and hippocampus are activated (Clifford et al., 1987). Interestingly, 
hippocampal neurons exhibit an enhanced vulnerability to different types of 
neuropathogenesis (Mattson, 1990; Bahr et al., 1994), and organophosphate 
compounds have a significant effect on this brain region (Crino et al., 2002 ; 
Harrison et al., 2004), particularly due to the high density of cholinergic and 
glutamatergic innervations.  
 Brain damage caused by organophosphate intoxication is not restricted 
to the primary event induced by the poison, but secondary events associated 
with the anticholinesterase-induced cellular toxicity were observed across 
several studies in different cell types and brain regions (see Table 1). In the 
hippocampus, the anticholinesterase effect was observed in vitro and in vivo 
by Nallapanemi and colleagues (2006), confirming the ability of Pxn to inhibit 
the enzyme acetylcholinesterase in this brain region. Pxn exposure comprises 
different cellular disturbances such as reactive astrocytes, synaptic marker 
changes, morphological changes, and oxidative stress (Kang et al., 2011; Yu 
et al., 2012). As found by Jafari and colleagues (2012), Pxn-mediated 
oxidative damage presented itself not only in brain tissue but also in other 
organs such as the liver, heart, kidney and spleen.  
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Table 1.  
Pxn-induced cellular disturbances in different brain regions 
Molecular Changes                             Brain Region / Cells                          Reference 
reduced cholinesterase activity                 hippocampus                                Nallapanemi et al., 2006  
                                                neuroblastoma cell line                    Ehrich et al., 1997 
enhanced glutamate release         hippocampus and amygdala                    Kozhemyakin et al., 2010 
diminished GABA uptake               hippocampus and cortex                         Mohammadi et al., 2008 
reduced cell viability               neuroblastoma cell line                           Prins et al., 2010 
oxidative damage                            human salivary gland cell line                 Prins et al., 2014 
 
 In a recent study of Pxn exposure using stable explants of brain tissue, 
indications of oxidative stress and induced alterations to β1-class integrin 
adhesion molecules were found in correspondence with synaptic compromise 
(Farizatto et al., 2017). This synaptic compromise was characterized by 
selectivity of the presynaptic components it affected. Note that, as shown in 
Table 2, the new study found Pxn-mediated synaptotoxicity associated with 
oxidative stress as well as integrin adhesion responses both in vitro and in vivo. 
These molecular indicators of toxicity show consistency with regards Pxn-
mediated cellular changes across both models. These results further indicate 
the usefulness of screening studies with brain slices to better understand this 
type of toxin exposure so that it may be properly treated in such a way that 
offsets damage caused by the toxic cascade. 
Table 2.  
Pxn exposure leads to oxidative, adhesive, and synaptic changes in both in vitro and in vivo 
experiments.  
       Toxic Changes            Pxn-treated hippocampal slice cultures           Pxn-treated rats      
Oxidative stress                      increased 4-HNE adducts              increased 4-HNE adducts                  
        Adhesion response                 enhanced β1 integrin levels            enhanced β1 integrin levels                                  
     Synaptic decline                     reduced synapsin IIb and               reduced synapsin IIb levels                                                                                                                                                                                                             
synaptophysin levels 
 
 OP agents like Pxn may initiate synaptic deterioration in which the 
presynaptic markers appear to be more susceptible than postsynaptic markers 
(Kozhemyakin et al., 2010; Farizatto et al., 2017). The synaptic decline profile 
induced by Pxn can be compared to 1) synaptic disruption reported in 
excitotoxicity studies using hippocampal slice cultures (Bahr et al., 2002; 
Karanian et al., 2005; Piwońska et al., 2016) and 2) hippocampal slice synaptic 
declines from protein accumulation stress studies (Bendiske and Bahr, 2003; 
Butler et al., 2007; Wisniewski et al., 2011). Synaptic pathology after Pxn 
exposure has been shown in vitro and in vivo (see Table 2). The illustrative 
image in Figure 1 shows the synaptic events that are linked to inhibition of 
acetylcholinesterase. Pxn exposure leads to excess of acetylcholine activity 
and enhanced glutamate release, and one or both of these changes can lead to 
seizure, excitotoxicity and brain damage. These findings suggest that Pxn 
affects the native composition of important CNS synapses and their control of 
important brain functions. 
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Figure 1: Schematic Illustration of paraoxon-mediated cellular disturbances on brain tissue.  
 
 The anticholinesterase paraoxon leads to over-excitatory activity 
through excess of acetylcholine and enhanced glutamate release in the 
synaptic cleft, which elicits a cholinergic crisis and excitotoxic damage. Note, 
the potent inhibition of the enzyme acetylcholinesterase (AChE) by paraoxon 
exposure also causes presynaptic compromise, adhesion response and 
oxidative damage.  
 The degradation of the neurotransmitter acetylcholine by 
acetylcholinesterase is critical for the maintenance and homeostasis of 
synaptic integrity and communication. Acute and chronic exposure to 
compounds like Pxn can lead to neurotoxic effects associated with the human 
conditions called cholinergic syndrome, intermediate syndrome, 
organophosphate-induced delayed polyneuropathy, and chronic 
organophosphate-induced neuropsychiatric disorder. It is very important to 
understand the actions of related neurotoxins and environmental toxins on 
synaptic mechanisms and CNS pathways, including cholinergic, 
glutamatergic, GABAergic, as well as antioxidant systems. The brain’s 
susceptibility to anticholinesterase toxins and the distinct effects on synapses 
can leave exposed individuals vulnerable to symptoms and neurological 
problems for the rest of their lives. 
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